Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenerimod in Systemic Lupus Erythematosus and Active Lupus Nephritis (LUMIOS)
NCT07201129Phase 3Recruiting
- Sponsor
- Viatris
- Start
- Feb 2026
- Primary completion
- Aug 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cenerimod in lupus nephritis (LN), systemic lupus erythematosus (SLE), sponsored by Viatris. Started Feb 2026; status: recruiting.
02
Drugs
cenerimod
03
Conditions
lupus nephritis (LN)systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT07201129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07201129.